Cord tissue patches aim to heal stubborn diabetic foot sores

NCT ID NCT07449975

Not yet recruiting Disease control Sponsor: StimLabs Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether two skin substitutes made from donated human umbilical cord tissue can help close hard-to-heal diabetic foot ulcers. About 272 adults with diabetes and a foot ulcer will receive either standard wound care alone or standard care plus weekly applications of one of the cord-based products for up to 12 weeks. The main goal is to see if more ulcers close completely with the added treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dehydrated human umbilical cord-based skin substitutes (Corplex P, Theracor)
What this could lead to: If successful, this could provide a new treatment option that helps heal stubborn diabetic foot ulcers faster and more completely.
What could go wrong: This is an early-stage trial with no phase, so results are uncertain. The devices may not work better than standard care, and there are risks like infection or allergic reaction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC FOOT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Diabetic Foot Foot Ulcer ulcer of lower limbs

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC FOOT DIABETIC FOOT ULCER (DFU) FOOT ULCER ULCER FOOT

More trials for these conditions

Other studies related to the condition(s) this trial covers.